Evidence map›Paper›PMID 40165352›Full record

ArticleThe American journal of case reports2025

Early-Onset COPD and Lung Cancer: Case Studies Highlighting Diagnostic Challenges in Younger Patients.

Robert Uliński, Piotr Korczyński, Joanna Domagała-Kulawik

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert UlińskiDoctoral School, Medical University of Warsaw, Warsaw, Poland.
Piotr KorczyńskiDepartment of Internal Medicine, Pulmonary Diseases, and Allergy, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0003-2826-4430
Joanna Domagała-KulawikInstitute of Clinical Sciences, Maria Skłodowska-Curie Medical Academy, Warsaw, Poland.ORCID 0000-0002-2260-3676

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The coexistence of lung cancer with COPD has received increasing attention in recent years. These 2 entities are attributed to older age, with a mean age of around 70 years old. Here, we present 3 fatal cases of lung cancer and COPD in uncommonly young patients (45-55 years old). CASE REPORT The first patient, 46-year-old man, reported progressive tiredness, and recurrent sub-febrile states, without recovery despite empiric treatment with 3 antibiotics. He was diagnosed with SCC and referred for chemoradiotherapy, but he died within 6 months. The second patient was 53-year-old women with hemoptysis, tiredness, loss of weight, spine pain, and cough, who was first diagnosed with pneumonia. Her first bronchoscopy was not diagnostic. A second bronchoscopy performed 2 weeks later was successful and she was diagnosed with large-cell carcinoma. She was referred for chemoradiotherapy, but died within 1 month. The third patient was 50-year-old women with chest pain radiating to her left shoulder and hoarseness. She was diagnosed with advanced SCLC, and was referred immediately for chemotherapy with immunotherapy, but did not respond well to treatment and died a few months later. CONCLUSIONS Age seems to be one of the factors that can delay cancer diagnosis. To the best of our knowledge, the literature contains no reports about young patients with coexistence of lung cancer and COPD. We emphasize the importance of these diseases in differential diagnosis in younger patients when reported with systemic symptoms.

Indexed as

Lung NeoplasmsPulmonary Disease, Chronic ObstructiveAge of OnsetFatal OutcomeFemaleHumansMaleMiddle Aged

Identifiers

PMID40165352
PMCPMC11970535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.